CMIC, more than CRO Our Performance

Business consultingBusiness consulting

Provision of consultation for successful business in Japan
Since first carrying out business consulting for overseas bio-venture enterprises targeting Japan, CMIC has supported a number of healthcare businesses.
The CMIC Group uses its know-how and network of personnel to provide consultations for all aspects of the healthcare business, from pharmaceuticals and diagnostic agents to cosmetics and food products.

Characteristics

We are pleased to be able to pass on to clients our experience gained from consulting work in a large number of healthcare fields.

The president's commitment
CMIC founder Kazuo Nakamura offers consultations regarding the secret to business success
CMIC's specialists are located at each landmark in business development. They are professionals in the following:
  1. Professionals experienced in business development in relevant areas (medicine, pharmaceutical sciences, pharmacology, toxicology, etc.)
  2. CMC and related areas
  3. Pharmaceutical affairs and administrations
  4. HR development
  5. Corporate law (corporate lawyers)
  6. Corporate financing and accounting
  7. Marketing
  8. Scientific advisors
Science-based analysis and review by professional staff
  1. Specialists in pharmaceutical strategy and consulting examine every aspect of business development and pharmaceutical affairs.
  2. CMIC's specialized staff in the business development division offers broad perspectives in business proposals, including proposals for corporate cquisitions.
  3. Business value estimation by CMIC-MPSS, our affiliate specialized in marketing
  4. Centered on the Scientific Advisor, CMIC provides an inside and outside network of specialists.
Solutions and Services
  • Business consultation in the healthcare industry
  • Corporate survey and planning for Japanese and overseas company acquisition
  • Planning and management of targeted discussions by inside and outside specialists (unbiased opinion survey)
  • Proposals for and reporting of business risk assessment